Cargando…

Radiolabeled fibroblast activation protein inhibitors in the evaluation of myocardial fibrosis

Detalles Bibliográficos
Autores principales:	Su, Xiangyu, Zhao, Yiheng, Zhou, Xiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10538885/ https://www.ncbi.nlm.nih.gov/pubmed/37464383 http://dx.doi.org/10.1097/CM9.0000000000002590

Ejemplares similares

Evans blue-modified radiolabeled fibroblast activation protein inhibitor as long-acting cancer therapeutics
por: Wen, Xuejun, et al.
Publicado: (2022)

Radiolabeled PSMA Inhibitors
por: Neels, Oliver C., et al.
Publicado: (2021)

Synthesis, radiolabeling, and evaluation of a (4-quinolinoyl)glycyl-2-cyanopyrrolidine analogue for fibroblast activation protein (FAP) PET imaging
por: Zhang, Ni, et al.
Publicado: (2023)

New Frontiers in Cancer Imaging and Therapy Based on Radiolabeled Fibroblast Activation Protein Inhibitors: A Rational Review and Current Progress
por: Imlimthan, Surachet, et al.
Publicado: (2021)

Targeting telomerase with radiolabeled inhibitors
por: Waghorn, Philip A., et al.
Publicado: (2017)

Myocardial fibrosis occurs in non-hospitalised patients with chronic symptoms after COVID-19
por: Krishnan, A., et al.
Publicado: (2022)

Radiolabeled Small Molecule Protein Kinase Inhibitors for Imaging with PET or SPECT
por: Hicks, Justin W., et al.
Publicado: (2010)

Highlighting Fibroblasts Activation in Fibrosis: The State-of-The-Art Fibroblast Activation Protein Inhibitor PET Imaging in Cardiovascular Diseases
por: Cui, Yan, et al.
Publicado: (2023)

Immune-related genetic prognostic index to predict prognosis and immune checkpoint inhibitor therapy efficiency in acute myeloid leukemia
por: Cao, Xunhong, et al.
Publicado: (2023)

Evaluation of Radiolabeled Girentuximab In Vitro and In Vivo
por: Basaco, Tais, et al.
Publicado: (2018)

A Case of Acute Myocardial Infarction Induced by Selective Cyclooxygenase-2 Inhibitor
por: Seo, Kyoung-Woo, et al.
Publicado: (2017)

Is Fibrosis Really Fibrosis?
por: Vijayakumar, Bavithra, et al.
Publicado: (2021)

Central role of cardiac fibroblasts in myocardial fibrosis of diabetic cardiomyopathy
por: Cheng, Yanan, et al.
Publicado: (2023)

Radiolabeling of Cramoll 1,4: Evaluation of the Biodistribution
por: Ferreira de Carvalho Patricio, Beatriz, et al.
Publicado: (2011)

The Radiolabeling of [161Tb]-PSMA-617 by a Novel Radiolabeling Method and Preclinical Evaluation by In Vitro/In Vivo Methods
por: UYGUR, EMRE, et al.
Publicado: (2023)

Tumor Imaging Using Radiolabeled Matrix Metalloproteinase–Activated Anthrax Proteins
por: Elvina Xavier, Mary-Ann, et al.
Publicado: (2019)

Theragnostic Imaging Using Radiolabeled Antibodies and Tyrosine Kinase Inhibitors
por: Yoshimoto, Mitsuyoshi, et al.
Publicado: (2015)

Fibroblast function in COVID-19
por: Sahin, Mustafa, et al.
Publicado: (2021)

Evaluation of the Radiolabeled Boronic Acid-Based FAP Inhibitor MIP-1232 for Atherosclerotic Plaque Imaging
por: Meletta, Romana, et al.
Publicado: (2015)

Targeting Immune-Fibroblast Crosstalk in Myocardial Infarction and Cardiac Fibrosis
por: Amrute, Junedh M., et al.
Publicado: (2023)

Myocardial Fibrosis in Hypertrophic Cardiomyopathy: A Perspective from Fibroblasts
por: Schlittler, Maja, et al.
Publicado: (2023)

Global fibroblast activation throughout the left ventricle but localized fibrosis after myocardial infarction
por: Nagaraju, Chandan K., et al.
Publicado: (2017)

Radiolabeled Bombesin Analogs
por: Mansi, Rosalba, et al.
Publicado: (2021)

Silent Myocardial Ischemia:A challenge for the doctors
por: Wu, Zhoupeng, et al.
Publicado: (2014)

Preclinical evaluation of PAC1 targeting with radiolabeled Maxadilan
por: Joosten, Lieke, et al.
Publicado: (2017)

When is cystic fibrosis not cystic fibrosis? The importance of appropriately classifying patients
por: Faro, Albert, et al.
Publicado: (2022)

Comment on Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults
por: Scholand, Mary Beth, et al.
Publicado: (2022)

Reprogramming of fibroblasts to uterine glandular epithelium by a chemical cocktail induction
por: Yuan, Xuewei, et al.
Publicado: (2019)

Radiolabeled Dendrimers for Nuclear Medicine Applications
por: Zhao, Lingzhou, et al.
Publicado: (2017)

Comparison of the radiolabeled PSMA-inhibitor (111)In-PSMA-617 and the radiolabeled GRP-R antagonist (111)In-RM2 in primary prostate cancer samples
por: Schollhammer, Romain, et al.
Publicado: (2019)

Imaging using radiolabelled targeted proteins: radioimmunodetection and beyond
por: Garousi, Javad, et al.
Publicado: (2020)

Enzymatic Methods for the Site-Specific Radiolabeling of Targeting Proteins
por: Bolzati, Cristina, et al.
Publicado: (2021)

Normal RNAi response in human fragile × fibroblasts
por: Madsen, Charlotte, et al.
Publicado: (2009)

Recent Advances in the Development and Application of Radiolabeled Kinase Inhibitors for PET Imaging
por: Bernard-Gauthier, Vadim, et al.
Publicado: (2015)

Isoniazid and Pulmonary Fibrosis
por: Chung, Chae Uk, et al.
Publicado: (2015)

Fibroblast Activation Protein Activates Macrophages and Promotes Parenchymal Liver Inflammation and Fibrosis
por: Yang, Ai-Ting, et al.
Publicado: (2022)

Commentary on “Simple non-invasive biomarkers of advanced fibrosis in the evaluation of non-alcoholic fatty liver disease”
por: Kayadibi, Huseyin, et al.
Publicado: (2014)

Radiolabeled Nanoparticles for Multimodality Tumor Imaging
por: Xing, Yan, et al.
Publicado: (2014)

Prognostic value of tissue inhibitor of metalloproteinase-matrix metalloproteinase biomarkers at 30 days in patients with acute myocardial infarction without reperfusion therapy
por: Pang, Hui-Fang, et al.
Publicado: (2021)

Pharmacological targeting of BET proteins inhibits renal fibroblast activation and alleviates renal fibrosis
por: Xiong, Chongxiang, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_0edt2pvcg97elaf3q3iqfc2b3u